Download PDF
CC BY-NC-ND 4.0 · Journal of Social Health and Diabetes 2016; 04(01): 006-010
DOI: 10.4103/2321-0656.176570
Review Article
NovoNordisk Education Foundation

Opioid use and diabetes: An overview

Pawan Sharma
1   Department of Psychiatry, National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences (AIIMS), New Delhi, India
,
Yatan Pal Singh Balhara
1   Department of Psychiatry, National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences (AIIMS), New Delhi, India
2   Department of Psychiatry, International program in Addiction Studies, King′s College London, London, UK
3   Department of Psychiatry, International program in Addiction Studies, University of Adelaide, Adelaide, Australia
4   Department of Psychiatry, International program in Addiction Studies, Virginia Commonwealth University, Richmond, Virginia, USA
› Author Affiliations
Further Information

Publication History

Publication Date:
23 November 2018 (online)

   Permissions and Reprints

Abstract

Illicit opioids have emerged as a major public health problem over the past century. It continues to remain so in the current times. From the studies conducted among the animals, it has been clear that there are acute as well as chronic effects of opioids on the endocrine system. Diabetes has been recognized as a major public health concern and is expected to be a major problem in the coming decades. In this article, we shall discuss the effects of opioids in the glucose homeostasis in both the animal population and human population and its relation to diabetes.

Buprenorphine - diabetes mellitus - methadone - naltrexone - opioids
 

  • References

  • 1 Brownstein MJ. A brief history of opiates, opioid peptides, and opioid receptors. Proc Natl Acad Sci U S A 1993; 90: 5391-5393
    CrossrefPubMedGoogle Scholar
  • 2 Simon EJ, Hiller JM, Edelman I. Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat-brain homogenate. Proc Natl Acad Sci U S A 1973; 70: 1947-1949
    CrossrefPubMedGoogle Scholar
  • 3 Terenius L. Characteristics of the "receptor" for narcotic analgesics in synaptic plasma membrane fraction from rat brain. Acta Pharmacol Toxicol (Copenh) 1973; 33: 377-384
    PubMedGoogle Scholar
  • 4 Pert CB, Snyder SH. Opiate receptor: Demonstration in nervous tissue. Science 1973; 179: 1011-1014
    CrossrefPubMedGoogle Scholar
  • 5 Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE. The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 1976; 197: 517-532
    PubMedGoogle Scholar
  • 6 WDR 2014 - Use of drugs. Tableau Software. Available from: http://public.tableau.com/views/WDR2014-Useofdrugs/Map?:embed=yand:showVizHome=noand:host_url=http%3A%2F%2Fpublic.tableausoftware.com%2Fand:tabs=noand:toolbar=yesand:animate_transition=yesand:display_static_image=yesand:display_spinner=yesand:display_overlay=yesand:display_count=yesand:showVizHome=noand:display_footer=noand:loadOrderID=0 [Last accessed on 2015 Oct 24].
    Google Scholar
  • 7 Ray R. The Extent, Pattern and Trends of Drug Abuse in India: National Survey. Ministry of Social Justice and Empowerment, Government of India and United Nations Office on Drugs and Crime. Regional Office for South Asia; 2004
    Google Scholar
  • 8 Pfeiffer A, Herz A. Endocrine actions of opioids. Horm Metab Res 1984; 16: 386-397
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Katz N, Mazer NA. The impact of opioids on the endocrine system. Clin J Pain 2009; 25: 170-175
    CrossrefPubMedGoogle Scholar
  • 10 Brennan MJ. The effect of opioid therapy on endocrine function. Am J Med 2013; 126 (Suppl. 01) S12-S18
    CrossrefPubMedGoogle Scholar
  • 11 Vuong C, Van Uum SH, O′Dell LE, Lutfy K, Friedman TC. The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Rev 2010; 31: 98-132
    CrossrefPubMedGoogle Scholar
  • 12 American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014; 37 (Suppl. 01) S81-S90
    CrossrefPubMedGoogle Scholar
  • 13 Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014; 103: 137-149
    CrossrefPubMedGoogle Scholar
  • 14 Levine AS, Morley JE, Gosnell BA, Billington CJ, Bartness TJ. Opioids and consummatory behavior. Brain Res Bull 1985; 14: 663-672
    CrossrefPubMedGoogle Scholar
  • 15 Gosnell BA, Krahn DD. The effects of continuous morphine infusion on diet selection and body weight. Physiol Behav 1993; 54: 853-859
    CrossrefPubMedGoogle Scholar
  • 16 Grandison L, Guidotti A. Stimulation of food intake by muscimol and beta endorphin. Neuropharmacology 1977; 16: 533-536
    CrossrefPubMedGoogle Scholar
  • 17 Leshem M. Morphine-induced anorexia in lateral hypothalamic rats. Psychopharmacology (Berl) 1981; 75: 48-53
    CrossrefPubMedGoogle Scholar
  • 18 Buck M, Marrazzi MA. Atypical responses to morphine in mice: A possible relationship to anorexia nervosa?. Life Sci 1987; 41: 765-773
    CrossrefPubMedGoogle Scholar
  • 19 Marks-Kaufman R, Kanarek RB. Morphine selectively influences macronutrient intake in the rat. Pharmacol Biochem Behav 1980; 12: 427-430
    CrossrefPubMedGoogle Scholar
  • 20 Leshem M. Morphine induces delayed anorexia in rats. Psychopharmacology (Berl) 1988; 94: 254-258
    PubMedGoogle Scholar
  • 21 Anghel A, Jamieson CA, Ren X, Young J, Porche R, Ozigbo E. et al. Gene expression profiling following short-term and long-term morphine exposure in mice uncovers genes involved in food intake. Neuroscience 2010; 167: 554-566
    CrossrefPubMedGoogle Scholar
  • 22 Recant L, Voyles N, Wade A, Awoke S, Bhathena SJ. Studies on the role of opiate peptides in two forms of genetic obesity: Ob/ob mouse and fa/fa rat. Horm Metab Res 1983; 15: 589-593
    Article in Thieme ConnectPubMedGoogle Scholar
  • 23 Khawaja XZ, Bailey CJ, Green IC. Central mu, delta, and kappa opioid binding sites, and brain and pituitary beta-endorphin and met-enkephalin in genetically obese (ob/ob) and lean mice. Life Sci 1989; 44: 1097-1105
    CrossrefPubMedGoogle Scholar
  • 24 Bailey CJ, Flatt PR. Increased responsiveness to glucoregulatory effect of opiates in obese-diabetic ob/ob mice. Diabetologia 1987; 30: 33-37
    CrossrefPubMedGoogle Scholar
  • 25 Sadava D, Alonso D, Hong H, Pettit-Barrett DP. Effect of methadone addiction on glucose metabolism in rats. Gen Pharmacol 1997; 28: 27-29
    CrossrefPubMedGoogle Scholar
  • 26 Chen SR, Sweigart KL, Lakoski JM, Pan HL. Functional mu opioid receptors are reduced in the spinal cord dorsal horn of diabetic rats. Anesthesiology 2002; 97: 1602-1608
    CrossrefPubMedGoogle Scholar
  • 27 Virmani A, Binienda ZK, Ali SF, Gaetani F. Metabolic syndrome in drug abuse. Ann N Y Acad Sci 2007; 1122: 50-68
    CrossrefPubMedGoogle Scholar
  • 28 Mattoo SK, Chakraborty K, Basu D, Ghosh A, Vijaya KumarKG, Kulhara P. Prevalence & correlates of metabolic syndrome in alcohol & opioid dependent inpatients. Indian J Med Res 2011; 134: 341-348
    PubMedGoogle Scholar
  • 29 Karam GA, Reisi M, Kaseb AA, Khaksari M, Mohammadi A, Mahmoodi M. Effects of opium addiction on some serum factors in addicts with non-insulin-dependent diabetes mellitus. Addict Biol 2004; 9: 53-58
    CrossrefPubMedGoogle Scholar
  • 30 Giugliano D. Morphine, opioid peptides, and pancreatic islet function. Diabetes Care 1984; 7: 92-98
    CrossrefPubMedGoogle Scholar
  • 31 Sood A, Thakur V, Ahuja MM. Effect of chronic opioid administration on glycosylated haemoglobin levels in heroin addicts. Indian J Med Res 1989; 90: 51-54
    PubMedGoogle Scholar
  • 32 Atkinson RL, Berke LK, Drake CR, Bibbs ML, Williams FL, Kaiser DL. Effects of long-term therapy with naltrexone on body weight in obesity. Clin Pharmacol Ther 1985; 38: 419-422
    CrossrefPubMedGoogle Scholar
  • 33 Maggio CA, Presta E, Bracco EF, Vasselli JR, Kissileff HR, Pfohl DN. et al. Naltrexone and human eating behavior: A dose-ranging inpatient trial in moderately obese men. Brain Res Bull 1985; 14: 657-661
    CrossrefPubMedGoogle Scholar
  • 34 Mitchell JE, Morley JE, Levine AS, Hatsukami D, Gannon M, Pfohl D. High-dose naltrexone therapy and dietary counseling for obesity. Biol Psychiatry 1987; 22: 35-42
    CrossrefPubMedGoogle Scholar
  • 35 Giugliano D, Salvatore T, Cozzolino D, Ceriello A, Torella R, D′Onofrio F. Sensitivity to beta-endorphin as a cause of human obesity. Metabolism 1987; 36: 974-978
    CrossrefPubMedGoogle Scholar
  • 36 De Marinis L, Mancini A, Valle D, Bianchi A, De Luca AM, Fulghesu AM. et al. Influence of chronic Naltrexone treatment on growth hormone and insulin secretion in obese subjects. Int J Obes Relat Metab Disord 1997; 21: 1076-1081
    CrossrefPubMedGoogle Scholar
  • 37 Kolarzyk E, Chrostek MajJ, Pach D, Janik A, Kwiatkowski J, Szurkowska M. Assessment of daily nutrition ratios of opiate-dependent persons before and after 4 years of methadone maintenance treatment. Przegl Lek 2005; 62: 368-372
    PubMedGoogle Scholar
  • 38 Zador D, Lyons WallPM, Webster I. High sugar intake in a group of women on methadone maintenance in south western Sydney, Australia. Addiction 1996; 91: 1053-1061
    CrossrefPubMedGoogle Scholar
  • 39 Rajs J, Petersson A, Thiblin I, Olsson-Mortlock C, Fredriksson A, Eksborg S. Nutritional status of deceased illicit drug addicts in Stockholm, Sweden - A longitudinal medicolegal study. J Forensic Sci 2004; 49: 320-329
    PubMedGoogle Scholar
  • 40 Passariello N, Giugliano D, Quatraro A, Consoli G, Sgambato S, Torella R. et al. Glucose tolerance and hormonal responses in heroin addicts. A possible role for endogenous opiates in the pathogenesis of non-insulin-dependent diabetes. Metabolism 1983; 32: 1163-1165
    CrossrefPubMedGoogle Scholar
  • 41 Brambilla F, Guerrini A, Guastalla A, Beretta P, Maio DD. Glucose-insulin metabolism in herion addicts. Neuropsychobiology 1976; 2: 341-349
    CrossrefPubMedGoogle Scholar
  • 42 Ghodse AH. Evaluation of blood glucose, insulin, growth hormone and cortisol response in heroin addicts. Pahlavi Med J 1977; 8: 141-156
    PubMedGoogle Scholar
  • 43 Giugliano D, Quatraro A, Consoli G, Stante A, Simeone V, Ceriello A. et al. Sodium salicylate restores the impaired insulin response to glucose and improves glucose tolerance in heroin addicts. Acta Diabetol Lat 1987; 24: 205-212
    CrossrefPubMedGoogle Scholar
  • 44 Tiras S, Haas V, Chevret L, Decobert M, Buisine A, Devictor D. et al. Nonketotic hyperglycemic coma in toddlers after unintentional methadone ingestion. Ann Emerg Med 2006; 48: 448-451
    CrossrefPubMedGoogle Scholar
  • 45 Leslie RD, Pyke DA, Stubbs WA. Sensitivity to enkephalin as a cause of non-insulin dependent diabetes. Lancet 1979; 1: 341-343
    PubMedGoogle Scholar
  • 46 Giugliano D, Ceriello A, di Pinto P, Saccomanno F, Gentile S, Cappiapuoti F. Impaired insulin secretion in human diabetes mellitus. The effect of naloxone-induced opiate receptor blockade. Diabetes 1982; 31: 367-370
    CrossrefPubMedGoogle Scholar
  • 47 Mason JS, Heber D. Endogenous opiates modulate insulin secretion in flushing noninsulin-dependent diabetics. J Clin Endocrinol Metab 1982; 54: 693-697
    CrossrefPubMedGoogle Scholar
  • 48 Azod L, Rashidi M, Afkhami-Ardekani M, Kiani G, Khoshkam F. Effect of Opium Addiction on Diabetes. Am J Drug Alcohol Abuse 2008; 34: 383-388
    CrossrefPubMedGoogle Scholar
  • 49 Shahani S, Braga-Basaria M, Basaria S. Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis. J Clin Endocrinol Metab 2008; 93: 2042-2049
    CrossrefPubMedGoogle Scholar
  • 50 Kapoor D, Goodwin E, Channer KS, Jones TH. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 2006; 154: 899-906
    CrossrefPubMedGoogle Scholar
  • 51 Awoke S, Voyles NR, Bhathena SJ, Tanenberg RJ, Recant L. Alterations of plasma opioid activity in human diabetics. Life Sci 1984; 34: 1999-2006
    CrossrefPubMedGoogle Scholar
  • 52 Giugliano D, Quatraro A, Consoli G, Ceriello A, Torella R, D′Onofrio F. Inhibitory effect of enkephalin on insulin secretion in healthy subjects and in non insulin-dependent diabetic subjects. Metabolism 1987; 36: 286-289
    CrossrefPubMedGoogle Scholar
  • 53 Karci A, Tasdogen A, Erkin Y, Aktaº G, Elar Z. The analgesic effect of morphine on postoperative pain in diabetic patients. Acta Anaesthesiol Scand 2004; 48: 619-624
    Google Scholar